Fasken Martineau DuMoulin LLP advised the Underwriter in connection with Medexus Pharmaceuticals’s offering. Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) closed its bought-deal public offering of 3,389,900...
You must be a Standard 1 Year member to access this content.
Fasken Martineau DuMoulin LLP advised Elemental Altus Royalties Corp. on the acquisition. Elemental Altus Royalties Corp. (TSXV: ELE) (OTCQX: ELEMF) completed the acquisition of two existing...
You must be a Standard 1 Year member to access this content.
Fasken Martineau DuMoulin LLP advised Elemental Altus Royalties Corp. on the transaction. Elemental Altus Royalties Corp. completed the acquisition of two existing royalties from RCF Opportunities Fund...
You must be a Standard 1 Year member to access this content.
Fasken Martineau DuMoulin LLP advised Canaccord Genuity Corp. on the matter. On October 4, 2023, Fission Uranium Corp. completed a bought deal offering of 7,731,092 common shares...
You must be a Standard 1 Year member to access this content.
Fasken Martineau DuMoulin advised Research Capital Corporation. PyroGenesis Canada Inc. (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY) (“PyroGenesis”) announced that it has closed its previously announced “best-efforts” brokered private placement...
You must be a Standard 1 Year member to access this content.
Fasken Martineau DuMoulin LLP advised BULGOLD Inc. in the transaction. BULGOLD Inc. (the “Company”) announced it has closed an approximately C$2.2 million ($1.67 million) non-brokered private placement offering...
You must be a Standard 1 Year member to access this content.
Fasken Martineau DuMoulin LLP advised Beacon Securities Limited in the transaction. Trigon Metals Inc. announced its brokered private placement offering of 25,000,000 units at a price of...
You must be a Standard 1 Year member to access this content.
Fasken represented Research Capital Corporation in the offering. Algernon Pharmaceuticals Inc. (“Algernon” or “the Company”), a Canadian clinical stage pharmaceutical development company, completed a rights offering...
You must be a Standard 1 Year member to access this content.
Fasken advised the Delta Resources, while Cassels acted for the underwriters in the transaction. Delta Resources Limited closed a “bought deal” private placement of (i) 7,143,000...
You must be a Standard 1 Year member to access this content.
Fasken Martineau DuMoulin LLP assisted Eastern Resources on the deal. St Charles Resources Inc., a capital pool company listed on the TSX Venture Exchange, completed its qualifying transaction with...
You must be a Standard 1 Year member to access this content.
Fasken Martineau DuMoulin LLP assisted the underwriters. On April 25, 2023, Quipt Home Medical Corp. (CVE:QIPT) closed an approximately C$42.5 million bought deal public offering and concurrent...
You must be a Standard 1 Year member to access this content.
Elemental’s financial advisor was Canaccord Genuity Limited, assisted by Wildeboer Dellelce LLP. Fasken Martineau DuMoulin LLP acted as legal counsel to Elemental. Longview Communications and Public...
You must be a Standard 1 Year member to access this content.
